Nitric Oxide to Improve Blood Flow in Sickle Cell Disease

NCT00009581 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

NIH

Sponsor class

Conditions

Sickle Cell Anemia

Interventions

DRUG: L-NMMA
DRUG: Acetylcholine

Sponsor

National Institutes of Health Clinical Center (CC)